The LIFE Study Group. Cardiovascular morbidity and mortality in subjects with type 2 diabetes with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. - Lindholm,L.H.; Ibsen,H.; Dahlöf,B.; Devereux,R.B.; Beevers,G.; de Faire,U.; Fyhrquist,F.; Julius,S.; Kjeldsen,S.E.; Kristiansson,K.; Lederballe-Pedersen,O.; Nieminen,M.S.; et al. (Lancet, 2002)